Wearable cardiac monitoring is catching arrhythmias in men who would never have scheduled the test that found them
Dr. Dereck Mush, MD, MBA
Element Science
Develops patch-based wearable cardioverter defibrillators for patients at risk of sudden cardiac arrest.
What they do
Element Science is developing a therapeutic wearable device, the Jewel Patch Wearable Cardioverter Defibrillator, which continuously monitors heart rhythms. The device uses machine learning to detect life-threatening arrhythmias and deliver therapeutic shocks when necessary to prevent sudden cardiac death.
The record
- Vertical
- Remote Monitoring & Wearables
- Sub-segment
- Cardiac monitoring
- Product type
- Device
- Stage
- Series C+
- Headquarters
- San Francisco, United States
- Region
- North America
- Founded
- 2015
- Total funding
- $145M raised
Notable investors: Third Rock Ventures, Deerfield Management, Qiming Venture Partners, GV.
Also in Remote Monitoring & Wearables
Related on The Signal
Dr. Dereck Mush, MD, MBA
Bridging the Last Mile of Acute Cardiology: Synthesized 3D Vectorcardiography at Home
Dr. Dereck Mush, MD, MBA
The Universal Telemetry Layer: Why Implicity's Cross-Vendor Remote Cardiac Platform Raised $40M
Dr. Dereck Mush, MD, MBA
Hardware Tiering and AI Coaching: How Google's Fitbit Edge Reshapes Continuous Monitoring Economics
Dr. Dereck Mush, MD, MBA